Real-World Experience of the Comparative Effectiveness and Safety of Combination Therapy with Remdesivir and Monoclonal Antibodies versus Remdesivir Alone for Patients with Mild-to-Moderate COVID-19 and Immunosuppression: A Retrospective Single-Center Study in Aichi, Japan

The coronavirus disease (COVID-19) pandemic continues to threaten global public health. Remdesivir and monoclonal antibodies have shown promise for COVID-19 treatment of patients who are immunocompromised, including those with cancer, transplant recipients, and those with autoimmune disorder. Howeve...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirai, Jun, Mori, Nobuaki, Sakanashi, Daisuke, Ohashi, Wataru, Shibata, Yuichi, Asai, Nobuhiro, Kato, Hideo, Hagihara, Mao, Mikamo, Hiroshige
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10538070/
https://www.ncbi.nlm.nih.gov/pubmed/37766358
http://dx.doi.org/10.3390/v15091952

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10538070/
https://www.ncbi.nlm.nih.gov/pubmed/37766358
http://dx.doi.org/10.3390/v15091952

Ejemplares similares